Press Releases

Date	Title and Summary	View
Toggle SummaryFeb 02, 2010	PRO-PHARMACEUTICALS CLOSES $325,000 TRANCHE	View HTML PRO-PHARMACEUTICALS CLOSES $325,000 TRANCHE 15.2 KB
Toggle SummaryDec 17, 2009	PRO-PHARMACEUTICALS ANNOUNCES SIGNIFICANT ADVANCE IN DEFINING DAVANAT®'s MECHANISM OF ACTION BASED ON EXPERIMENTS DONE AT THE UNIVERSITY OF MINNESOTA AND THE LUDWIG INSTITUTE IN BRUSSELS, BELGIUM Studies Demonstrate DAVANAT® Binds To Galectin-1 and Galectin-3 Receptors That Control Angiogenesis and the Tumor's Ability To Evade the Immune System	View HTML PRO-PHARMACEUTICALS ANNOUNCES SIGNIFICANT ADVANCE IN DEFINING DAVANAT®'s MECHANISM OF ACTION BASED ON EXPERIMENTS DONE AT THE UNIVERSITY OF MINNESOTA AND THE LUDWIG INSTITUTE IN BRUSSELS, BELGIUM 22.2 KB
Toggle SummaryDec 15, 2009	THE LUDWIG INSTITUTE AND PRO-PHARMACEUTICALS COLLABORATE TO TEST DAVANAT®'s ABILITY TO ENHANCE THE FUNCTION OF ANTI-TUMOR T LYMPHOCYTES Pro-Pharmaceuticals' DAVANAT® Targets Galectin Receptors on Cancer Cells and Removes Their Ability to Evade the Immune System	View HTML THE LUDWIG INSTITUTE AND PRO-PHARMACEUTICALS COLLABORATE TO TEST DAVANAT®'s ABILITY TO ENHANCE THE FUNCTION OF ANTI-TUMOR T LYMPHOCYTES 20.4 KB
Toggle SummaryDec 10, 2009	PRO-PHARMACEUTICALS CLOSES $325,000 TRANCHE	View HTML PRO-PHARMACEUTICALS CLOSES $325,000 TRANCHE 16.2 KB
Toggle SummaryNov 13, 2009	Pro-Pharmaceuticals Reports Third Quarter Financial Results	View HTML Pro-Pharmaceuticals Reports Third Quarter Financial Results 17.1 KB
Toggle SummaryNov 04, 2009	PRO-PHARMACEUTICALS CLOSES $310,000 TRANCHE; BRINGS TOTAL TO $4.1 MILLION OF $6.0 MILLION PRIVATE PLACEMENT	View HTML PRO-PHARMACEUTICALS CLOSES $310,000 TRANCHE; BRINGS TOTAL TO $4.1 MILLION OF $6.0 MILLION PRIVATE PLACEMENT 16.2 KB
Toggle SummaryOct 06, 2009	PRO-PHARMACEUTICALS CLOSES $325,000 TRANCHE; BRINGS TOTAL TO $3.8 MILLION OF $6.0 MILLION PRIVATE PLACEMENT	View HTML PRO-PHARMACEUTICALS CLOSES $325,000 TRANCHE; BRINGS TOTAL TO $3.8 MILLION OF $6.0 MILLION PRIVATE PLACEMENT 15.2 KB
Toggle SummarySep 24, 2009	PRO-PHARMACEUTICALS TO PRESENT A CORPORATE UPDATE AT THE MAXIM GROUP GROWTH CONFERENCE	View HTML PRO-PHARMACEUTICALS TO PRESENT A CORPORATE UPDATE AT THE MAXIM GROUP GROWTH CONFERENCE 13.7 KB
Toggle SummaryAug 26, 2009	PRO-PHARMACEUTICALS TO PRESENT A CORPORATE UPDATE AT THE RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE	View HTML PRO-PHARMACEUTICALS TO PRESENT A CORPORATE UPDATE AT THE RODMAN & RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE 13.7 KB
Toggle SummaryAug 24, 2009	Pro-Pharmaceuticals Appoints Arthur R. "Bobby" Greenberg to its Board of Directors	View HTML Pro-Pharmaceuticals Appoints Arthur R. "Bobby" Greenberg to its Board of Directors 16 KB